LOGO
LOGO

Weighty Matters: Viking To Showcase Potential Of Dual GLP-1/GIP Agonist VK2735 At ObesityWeek 2025

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
obesity 30102023 lt

ObesityWeek 2025, an annual international conference for obesity researchers and clinicians, is scheduled to take place from November 4 to 7 in Atlanta, Georgia. According to the latest data from the Centers for Disease Control and Prevention (CDC), obesity remains highly prevalent among U.S. adults - more than 100 million are living with obesity, and over 22 million have severe obesity. Obesity is defined as having a body mass index (BMI) of 30.0 or higher, while severe obesity is defined as a BMI of 40.0 or higher.

At the ObesityWeek 2025, Viking Therapeutics Inc. (VKTX) will be highlighting clinical data from its VK2735 obesity program on November 5, 2025.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update -June 15 - June 19, 2026

June 19, 2026 16:46 ET
Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.

RELATED NEWS